BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6109412)

  • 1. [Investigations of clobazam (Frisium) by combined gas chromatography/mass spectrometry (author's transl)].
    Gielsdorf W; Herper M
    Z Rechtsmed; 1980; 85(4):295-303. PubMed ID: 6109412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative determination of clobazam in serum and urine by gas chromatography, thin layer chromatography and fluorometry.
    Hajdú P; Uihlein M; Damm D
    J Clin Chem Clin Biochem; 1980 Apr; 18(4):209-14. PubMed ID: 7381374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analytical data of the new 1,5-benzodiazepine clobazam (Frisium) and its main metabolite nor-clobazam (author's transl)].
    Schütz H
    Arch Toxicol; 1978 Dec; 41(3):233-8. PubMed ID: 32864
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitative determination of clobazam in the plasma of epileptic patients by gas-liquid chromatography with electron-capture detection.
    Riva R; Tedeschi G; Albani F; Baruzzi A
    J Chromatogr; 1981 Sep; 225(1):219-24. PubMed ID: 7298748
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of direct-probe mass spectrometry as a toxicology confirmation method for demoxepam in urine following high-performance liquid chromatography.
    Essien H; Lai SJ; Binder SR; King DL
    J Chromatogr B Biomed Appl; 1996 Aug; 683(2):199-208. PubMed ID: 8891916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of clobazam, N-desmethylclobazam and their hydroxy metabolites in plasma and urine by high-performance liquid chromatography.
    Tomasini JL; Bun H; Coassolo P; Aubert C; Cano JP
    J Chromatogr; 1985 Oct; 343(2):369-77. PubMed ID: 4066878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clobazam and norclobazam quantitation in serum by capillary gas chromatography with electron-capture detection.
    LeGatt DF; McIntosh DP
    Clin Biochem; 1993 Jun; 26(3):159-63. PubMed ID: 8101142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micro-determination of clobazam and N-desmethylclobazam in plasma or serum by electron-capture gas chromatography.
    Badcock NR; Zoanetti GD
    J Chromatogr; 1987 Oct; 421(1):147-54. PubMed ID: 2892847
    [No Abstract]   [Full Text] [Related]  

  • 9. [Screening and detection of tetrazepam and its major metabolites].
    Schütz H; Ebel S; Fitz H
    Arzneimittelforschung; 1985; 35(7):1015-24. PubMed ID: 2864931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of benzodiazepines (clobazam, diazepam and their main active metabolites) in human plasma by column-switching high-performance liquid chromatography.
    Lacroix C; Wojciechowski F; Danger P
    J Chromatogr; 1993 Aug; 617(2):285-90. PubMed ID: 8104951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of unchanged clobazam in plasma by gas-liquid chromatography].
    Marliac Y; Barazi S
    Ann Pharm Fr; 1989; 47(4):213-20. PubMed ID: 2576905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electron-capture GLC determination of clobazam and desmethylclobazam in plasma.
    Greenblatt DJ
    J Pharm Sci; 1980 Nov; 69(11):1351-2. PubMed ID: 6109011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of clobazam, N-desmethyl clobazam and clonazepam in plasma by high performance liquid chromatography.
    Dusci LJ; Hackett LP
    Ther Drug Monit; 1987; 9(1):113-6. PubMed ID: 3576656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening of benzo- and thienodiazepines in urine with Emit ST and thin-layer chromatography within the scope of substance abuse].
    Gruhl H
    Z Rechtsmed; 1987; 98(4):221-8. PubMed ID: 2889301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic aspects of the interaction between clobazam and cimetidine.
    Grigoleit HG; Hajdú P; Hundt HK; Koeppen D; Malerczyk V; Meyer BH; Müller FO; Witte PU
    Eur J Clin Pharmacol; 1983; 25(1):139-42. PubMed ID: 6617718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening and detection of ketazolam and oxazolam].
    Schütz H; Fitz H; Suphachearabhan S
    Arzneimittelforschung; 1983; 33(4):507-12. PubMed ID: 6683527
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics of a single oral dose of clobazam in patients with liver disease.
    Monjanel-Mouterde S; Antoni M; Bun H; Botta-Frindlund D; Gauthier A; Durand A; Cano JP
    Pharmacol Toxicol; 1994 Jun; 74(6):345-50. PubMed ID: 7937568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid chromatography determination of clobazam and its major metabolite N-desmethylclobazam in human plasma.
    Brachet-Liermain A; Jarry C; Faure O; Guyot M; Loiseau P
    Ther Drug Monit; 1982; 4(3):301-5. PubMed ID: 7135459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLC-ECD determination of 1-(2-hydroxyethyl)-3-hydroxy-7-chloro-1,3-dihydro-5-(O-fluorophenyl)-2H-1,4-benzodiazepin-2-one (SAS 643) in plasma and urine and identification of its main biotransformation products.
    Mardente S; Bicchi C; Nano GM
    Ther Drug Monit; 1981; 3(4):351-6. PubMed ID: 6121404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. False negative results with benzodiazepine screening test.
    Badcock NR; Zoanetti GD
    J Clin Pathol; 1989 May; 42(5):557-8. PubMed ID: 2567296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.